Simple and robust high-throughput serum proteomics workflow with low-microflow LC–MS/MS
Analytical and Bioanalytical Chemistry · 2024
DOI: 10.1007/s00216-024-05603-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2024. Verfasst von Yoondam Seo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doping Control Center, Korea Institute of Science and Technology (KIST), Hwarang-Ro 14-Gil 5, Seongbuk-Gu, Seoul, 02792, Republic of Korea. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Proteomics, Workflow. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Science and Technology, Ministry of Food and Drug Safety.
Abstract (Originalsprache)
Clinical proteomics has substantially advanced in identifying and quantifying proteins from biofluids, such as blood, contributing to the discovery of biomarkers. The throughput and reproducibility of serum proteomics for large-scale clinical sample analyses require improvements. High-throughput analysis typically relies on automated equipment, which can be costly and has limited accessibility. In this study, we present a rapid, high-throughput workflow low-microflow LC–MS/MS method without automation. This workflow was optimized to minimize the preparation time and costs by omitting the depletion and desalting steps. The developed method was applied to data-independent acquisition (DIA) analysis of 235 samples, and it consistently yielded approximately 6000 peptides and 600 protein groups, including 33 FDA-approved biomarkers. Our results demonstrate that an 18-min DIA high-throughput workflow, assessed through intermittently collected quality control samples, ensures reproducibility and stability even with 2 µL of serum. It was successfully used to analyze serum samples from patients with diabetes having chronic kidney disease (CKD), and could identify five dysregulated proteins across various CKD stages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doping Control Center, Korea Institute of Science and Technology (KIST), Hwarang-Ro 14-Gil 5, Seongbuk-Gu, Seoul, 02792, Republic of Korea.
- Department of Chemical and Biological Engineering, Korea University, Seoul, 02841, Republic of Korea.
- Department of Internal Medicine, Seoul National University Hospital and Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
- Center for Advanced Biomolecular Recognition, Korea Institute of Science and Technology (KIST), Hwarang-Ro 14-Gil 5, Seongbuk-Gu, Seoul, 02792, Republic of Korea. hyunbeom@kist.re.kr.
- Department of HY-KIST Bio-Convergence, Hanyang University, Seoul, 04763, Republic of Korea. hyunbeom@kist.re.kr.
- Doping Control Center, Korea Institute of Science and Technology (KIST), Hwarang-Ro 14-Gil 5, Seongbuk-Gu, Seoul, 02792, Republic of Korea. mhophil@kist.re.kr.
Förderung
- Korea Institute of Science and Technology
- Ministry of Food and Drug Safety
Zitieren
APA
Seo, Y., Kang, I., Lee, H. J., Hwang, J., Kwak, S. H., Oh, M. K., Lee, H., & Min, H. (2024). Simple and robust high-throughput serum proteomics workflow with low-microflow LC–MS/MS. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-024-05603-3
Vancouver
Seo Y, Kang I, Lee HJ, Hwang J, Kwak SH, Oh MK, et al. Simple and robust high-throughput serum proteomics workflow with low-microflow LC–MS/MS. Analytical and Bioanalytical Chemistry. 2024. doi:10.1007/s00216-024-05603-3
BibTeX
@article{Seo2024,
author = {Seo, Yoondam and Kang, Inseon and Lee, Hyeon-Jeong and Hwang, Jiin and Kwak, Soo Heon and Oh, Min-Kyu and Lee, Hyunbeom and Min, Hophil},
title = {Simple and robust high-throughput serum proteomics workflow with low-microflow LC–MS/MS},
journal = {Analytical and Bioanalytical Chemistry},
year = {2024},
doi = {10.1007/s00216-024-05603-3}
}
EUVIMED